LUNSUMIO conc perf 30 mg/30 ml flac 30 ml
7680683140021
CH-68314
L01FX25
07.16.1.
1 / 3
google
Details
- Product number
- 6831402
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Solutio concentrata: mosunetuzumabum 30 mg, histidinum, acidum aceticum glaciale, methioninum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 30 ml.
Articles (1)
Lunsumio 30 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLC
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
|
SOLC
|
- | Substance | HNIDK |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 68314
- Drug name
- Lunsumio, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX25
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 09/02/2023
- Authorization expiration date
- 09/02/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LUNSUMIO conc perf 30 mg/30 ml flac 30 ml
- Description (DE)
- LUNSUMIO Inf Konz 30 mg/30 ml Durchstf 30 ml
- Market launch
- 09/02/2023
- Narcotic (BTM)
- No